Mefloquine, a Potent Anti-severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Drug as an Entry Inhibitor in vitro

Coronavirus disease 2019 (COVID-19) has caused serious public health, social, and economic damage worldwide and effective drugs that prevent or cure COVID-19 are urgently needed. Approved drugs including Hydroxychloroquine, Remdesivir or Interferon were reported to inhibit the infection or propagati...

Descripción completa

Detalles Bibliográficos
Autores principales: Shionoya, Kaho, Yamasaki, Masako, Iwanami, Shoya, Ito, Yusuke, Fukushi, Shuetsu, Ohashi, Hirofumi, Saso, Wakana, Tanaka, Tomohiro, Aoki, Shin, Kuramochi, Kouji, Iwami, Shingo, Takahashi, Yoshimasa, Suzuki, Tadaki, Muramatsu, Masamichi, Takeda, Makoto, Wakita, Takaji, Watashi, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119653/
https://www.ncbi.nlm.nih.gov/pubmed/33995308
http://dx.doi.org/10.3389/fmicb.2021.651403

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119653/
https://www.ncbi.nlm.nih.gov/pubmed/33995308
http://dx.doi.org/10.3389/fmicb.2021.651403

Ejemplares similares